NCT04950855

Brief Summary

During pregnancy many physiological changes and adaptations occur.Hormonal, hematological and hemodynamic changes are responsible for most of the ocular adaptations.We are planning to compare the choroid and retinal blood flow values and choroidal thickness of pregnant women and healthy non pregnant women with optical coherence tomography and optic coherence tomography angiography

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

June 26, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

November 2, 2021

Status Verified

November 1, 2021

Enrollment Period

4 months

First QC Date

June 24, 2021

Last Update Submit

November 1, 2021

Conditions

Keywords

PregnancyTomography, Optical CoherenceChoroidretina

Outcome Measures

Primary Outcomes (2)

  • Choroidal thickness

    Choroidal thickness is measured by optical coherence tomography

    40 weeks

  • Retinal thickness

    Retinal thickness is measured by optical coherence tomography

    40 weeks

Secondary Outcomes (4)

  • Foveal avascular zone(FAZ) area measurement

    40 weeks

  • Retinal vascular density

    40 weeks

  • Retinal nerve fiber layer thickness

    40 weeks

  • Ganglion cell layer measurement

    40 weeks

Study Arms (2)

Pregnant Women

Healty pregnant women between 18-45 years,with no history of eye surgery and systemical disease.In 1st , 2nd and 3rd trimesters the measurements will be repeated

Diagnostic Test: Optical Coherence Tomography,Optical Coherence Tomography Angiography(Topcon)

Control Group

Healty non-pregnant women between 18-45 years with no history of eye surgery and systemical disease.

Diagnostic Test: Optical Coherence Tomography,Optical Coherence Tomography Angiography(Topcon)

Interventions

Optical coherence tomography optical coherence tomography angiography

Also known as: Pachymetry, Otorefractometry, Tonometry, Blood Pressure Measurement
Control GroupPregnant Women

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Retinal and choroid thickness and retinal angiographic values will be measured in healthy pregnant population (1 time for each trimester,totally 3 times) and healty control group

You may qualify if:

  • Healthy pregnant women Age \> 18 years

You may not qualify if:

  • Systemical disease such as diabetes mellitus or hypertension
  • Refractive error; spherical equivalence \> 4 diopters
  • Ocular disease or surgery history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz University Hospital

Antalya, 07070, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Tomography, Optical CoherenceCorneal PachymetryTonometry, OcularBlood Pressure Determination

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative TechniquesDiagnostic Techniques, OphthalmologicalDiagnostic Techniques, CardiovascularPhysical Examination

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

June 24, 2021

First Posted

July 6, 2021

Study Start

June 26, 2021

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

November 2, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will share

Locations